Clincosm LogoSign in Get a demo

Funguria in Hospitalized Patients

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
Overall Status
Completed
CT.gov ID
NCT00138502
Collaborator
(none)
926
Enrollment
2
Locations
86.7
Duration (Months)
463
Patients Per Site
5.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This protocol will attempt to generate a detailed clinical profile of patients with funguria and identify subgroups of patients with funguria at high risk for candiduria and determine the relative risks for obtaining candiduria. In addition, it will look at identifying subgroups of patients with funguria at high risk for candidemia and identifying subgroups of patients with funguria at high risk for death. Finally, it will attempt to determine if funguria independently predicts fungemia or death. Data will be complemented by surveillance of a comparable population without funguria.

    Study Design

    Study Type:
    Observational
    Time Perspective:
    Prospective
    Official Title:
    The Significance of Funguria In Hospitalized Patients
    Study Start Date :
    Sep 17, 2001
    Actual Primary Completion Date :
    Dec 8, 2008
    Actual Study Completion Date :
    Dec 8, 2008

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A to 99 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:

      1. Subjects with fungi isolated from the urine of any colony count.

      2. Patients seen at either Harbor-UCLA Medical Center or Cedars Sinai Medical Center.

      Exclusion Criteria:
      1. Persons with a previously positive urine fungal culture during the current hospital admission.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Cedars Sinai Medical Center Los Angeles California United States 90048
      2 UCLA Center For Vaccine Research Torrance California United States 90509

      Sponsors and Collaborators

      • National Institute of Allergy and Infectious Diseases (NIAID)

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00138502
      Other Study ID Numbers:
      • 02-050
      First Posted:
      Aug 30, 2005
      Last Update Posted:
      Feb 4, 2019
      Last Verified:
      Oct 1, 2007
      Keywords provided by , ,
      Candidiasis, Funguria
      Additional relevant MeSH terms:
      Candidiasis

      Study Results

      No Results Posted as of Feb 4, 2019